ArticleCells2022

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Kazutaka Takehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.